| Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer H Shao, EM Mohamed, GG Xu, M Waters, K Jing, Y Ma, Y Zhang, ... Oncotarget 7 (4), 3832, 2015 | 124 | 2015 |
| Solving a Hamiltonian Path Problem with a bacterial computer J Baumgardner, K Acker, O Adefuye, ST Crowley, W DeLoache, ... Journal of biological engineering 3, 1-11, 2009 | 112 | 2009 |
| Inhibition of injury-induced cell proliferation in the dentate gyrus of the hippocampus impairs spontaneous cognitive recovery after traumatic brain injury D Sun, TE Daniels, A Rolfe, M Waters, R Hamm Journal of neurotrauma 32 (7), 495-505, 2015 | 96 | 2015 |
| Interleukin-13 receptor alpha 2 cooperates with EGFRvIII signaling to promote glioblastoma multiforme JP Newman, GY Wang, K Arima, SP Guan, MR Waters, WK Cavenee, ... Nature communications 8 (1), 1913, 2017 | 89 | 2017 |
| RelB/p50 complexes regulate cytokine-induced YKL-40 expression R Bhardwaj, JW Yester, SK Singh, DD Biswas, MJ Surace, MR Waters, ... The Journal of Immunology 194 (6), 2862-2870, 2015 | 66 | 2015 |
| ABCC1-exported sphingosine-1-phosphate, produced by sphingosine kinase 1, shortens survival of mice and patients with breast cancer A Yamada, M Nagahashi, T Aoyagi, WC Huang, S Lima, NC Hait, A Maiti, ... Molecular Cancer Research 16 (6), 1059-1070, 2018 | 65 | 2018 |
| Long-term sleep disturbance and prescription sleep aid use among cancer survivors in the United States AN Slade, MR Waters, NA Serrano Supportive Care in Cancer 28, 551-560, 2020 | 46 | 2020 |
| RelB acts as a molecular switch driving chronic inflammation in glioblastoma multiforme MR Waters, AS Gupta, K Mockenhaupt, LSN Brown, DD Biswas, ... Oncogenesis 8 (6), 37, 2019 | 45 | 2019 |
| Sphingosine kinase 1 activation by estrogen receptor α36 contributes to tamoxifen resistance in breast cancer MA Maczis, M Maceyka, MR Waters, J Newton, M Singh, MF Rigsby, ... Journal of lipid research 59 (12), 2297-2307, 2018 | 37 | 2018 |
| BPTF inhibits NK cell activity and the abundance of natural cytotoxicity receptor co-ligands K Mayes, Z Elsayed, A Alhazmi, M Waters, SG Alkhatib, M Roberts, ... Oncotarget 8 (38), 64344, 2017 | 35 | 2017 |
| Stereotactic body radiation therapy in the treatment of ovarian cancer RO Kowalchuk, MR Waters, KM Richardson, K Spencer, JM Larner, ... Radiation Oncology 15, 1-10, 2020 | 22 | 2020 |
| RelB controls adaptive responses of astrocytes during sterile inflammation AS Gupta, MR Waters, DD Biswas, LN Brown, MJ Surace, C Floros, ... Glia 67 (8), 1449-1461, 2019 | 22 | 2019 |
| Sphingosine-1-phosphate inhibits IL-1–induced expression of CC motif ligand 5 via c-Fos–dependent suppression of IFN-β amplification loop JW Yester, L Bryan, MR Waters, B Mierzenski, DD Biswas, AS Gupta, ... The FASEB Journal 29 (12), 4853, 2015 | 20 | 2015 |
| STAT3 suppresses Wnt/β-catenin signaling during the induction phase of primary Myf5+ brown adipogenesis MT Cantwell, JS Farrar, JC Lownik, JA Meier, M Hyun, V Raje, MR Waters, ... Cytokine 111, 434-444, 2018 | 18 | 2018 |
| Unlocking the power of CHATGPT, artificial intelligence, and large language models: practical suggestions for radiation oncologists MR Waters, S Aneja, JC Hong Practical Radiation Oncology 13 (6), e484-e490, 2023 | 17 | 2023 |
| Integrating imaging and RNA-seq improves outcome prediction in cervical cancer J Zhang, R Rashmi, M Inkman, K Jayachandran, F Ruiz, MR Waters, ... The Journal of clinical investigation 131 (5), 2021 | 16 | 2021 |
| Stereotactic body radiation therapy for spinal metastases: a novel local control stratification by spinal region RO Kowalchuk, MR Waters, KM Richardson, K Spencer, JM Larner, ... Journal of Neurosurgery: Spine 34 (2), 267-276, 2020 | 13 | 2020 |
| Stereotactic radiosurgery for the treatment of bulky spine metastases RO Kowalchuk, MR Waters, KM Richardson, KM Spencer, JM Larner, ... Journal of Neuro-Oncology 148, 381-388, 2020 | 12 | 2020 |
| p38MAPKα Stromal Reprogramming Sensitizes Metastatic Breast Cancer to Immunotherapy DV Faget, X Luo, MJ Inkman, Q Ren, X Su, K Ding, MR Waters, GK Raut, ... Cancer Discovery 13 (6), 1454-1477, 2023 | 10 | 2023 |
| CT-based online adaptive radiotherapy improves target coverage and organ at risk (OAR) avoidance in stereotactic body radiation therapy (SBRT) for prostate cancer M Waters, A Price, E Laugeman, L Henke, G Hugo, H Stowe, N Andruska, ... Clinical and Translational Radiation Oncology 44, 100693, 2024 | 7 | 2024 |
